These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37263844)

  • 1. Humoral response to COVID-19 vaccination and maintenance hemodialysis: Correspondence.
    Mungmunpuntipantip R; Wiwanitkit V; Kleebayoon A
    Med Clin (Barc); 2023 Oct; 161(7):315-316. PubMed ID: 37263844
    [No Abstract]   [Full Text] [Related]  

  • 2. Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis.
    Grupper A; Sharon N; Finn T; Cohen R; Israel M; Agbaria A; Rechavi Y; Schwartz IF; Schwartz D; Lellouch Y; Shashar M
    Clin J Am Soc Nephrol; 2021 Jul; 16(7):1037-1042. PubMed ID: 33824157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Humoral Responses of Hemodialysis Patients after COVID-19 Vaccination with BNT162b2.
    Speer C; Göth D; Benning L; Buylaert M; Schaier M; Grenz J; Nusshag C; Kälble F; Kreysing M; Reichel P; Töllner M; Hidmark A; Ponath G; Schnitzler P; Zeier M; Süsal C; Morath C; Klein K
    Clin J Am Soc Nephrol; 2021 Jul; 16(7):1073-1082. PubMed ID: 34031181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Vaccination in Hemodialysis Patients Correspondence.
    Mungmunpuntipantip R; Wiwanitkit V
    High Blood Press Cardiovasc Prev; 2022 May; 29(3):311. PubMed ID: 35258795
    [No Abstract]   [Full Text] [Related]  

  • 5. Humoral Response to Third Dose of SARS-CoV-2 Vaccines in the CKD Spectrum.
    Quiroga B; Soler MJ; Ortiz A; Orero E; Tejedor S; Mantecón CJJ; Gómez Pérez VO; Marín Franco AJ; Alfaro Sánchez C; Puerta Carretero M; Jaldo Rodríguez MT; Carnerero Di Riso MA; Martínez S; González CC; Cervienka M; Macías Carmona N; Arroyo D; Pérez Del Valle KM; de Arriba G; Mazuecos A; Cazorla JM; Pereira M; González Parra E; Sánchez Márquez MG; Lancho Novillo C; Toyos Ruiz C; Aguilar Cervera MC; Muñoz Ramos P; Sánchez Horrillo A; Jimeno Martín I; Toapanta N; Cigarrán Guldris S; Folgueiras López M; Valero San Cecilio R; Villacorta Linaza B; Minguela Pesquera I; Santana Estupiñán R; Zamora R; Soriano S; Muñoz de Bustillo E; Pizarro Sánchez MS; Martínez Puerto AI; Yugueros A; Muñiz Pacios L; Leyva A; Rojas J; Gansevoort RT; de Sequera P;
    Clin J Am Soc Nephrol; 2022 Jun; 17(6):872-876. PubMed ID: 35551070
    [No Abstract]   [Full Text] [Related]  

  • 6. Humoral immunogenicity and tolerability of heterologous ChAd/BNT compared with homologous BNT/BNT and ChAd/ChAd SARS-CoV-2 vaccination in hemodialysis patients : A multicenter prospective observational study.
    Haase M; Lesny P; Anderson M; Cloherty G; Stec M; Haase-Fielitz A; Haarhaus M; Santos-Araújo C; Veiga PM; Macario F
    J Nephrol; 2022 Jun; 35(5):1467-1478. PubMed ID: 35084719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral Immune Response to COVID-19 Vaccination in Hemodialysis Patients: A Retrospective, Observational Case-Control Pilot Study.
    Piscitani L; Del Pinto R; Basili A; Tunno M; Ferri C
    High Blood Press Cardiovasc Prev; 2022 Mar; 29(2):163-167. PubMed ID: 34978702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients.
    Danthu C; Hantz S; Dahlem A; Duval M; Ba B; Guibbert M; El Ouafi Z; Ponsard S; Berrahal I; Achard JM; Bocquentin F; Allot V; Rerolle JP; Alain S; Touré F
    J Am Soc Nephrol; 2021 Sep; 32(9):2153-2158. PubMed ID: 34135083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.
    Hsu CM; Weiner DE; Manley HJ; Aweh GN; Ladik V; Frament J; Miskulin D; Argyropoulos C; Abreo K; Chin A; Gladish R; Salman L; Johnson D; Lacson EK
    Clin J Am Soc Nephrol; 2022 Mar; 17(3):403-413. PubMed ID: 35144972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral Response to mRNA versus an Adenovirus Vector-Based SARS-CoV-2 Vaccine in Dialysis Patients.
    Mulhern JG; Fadia A; Patel R; Ficociello LH; Willetts J; Dahne-Steuber IA; Pollan MC; Mullon C; DeLisi J; Johnson C; Mysayphonh C; Kossmann RJ; Anger MS; Hymes JL
    Clin J Am Soc Nephrol; 2021 Nov; 16(11):1720-1722. PubMed ID: 34312162
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis.
    Anand S; Montez-Rath ME; Han J; Garcia P; Cadden L; Hunsader P; Kerschmann R; Beyer P; Dittrich M; Block GA; Boyd SD; Parsonnet J; Chertow GM
    J Am Soc Nephrol; 2021 Oct; 32(10):2435-2438. PubMed ID: 34117129
    [No Abstract]   [Full Text] [Related]  

  • 12. Impaired Humoral but Substantial Cellular Immune Response to Variants of Concern B1.1.7 and B.1.351 in Hemodialysis Patients after Vaccination with BNT162b2.
    Thieme CJ; Blazquez-Navarro A; Safi L; Kaliszczyk S; Paniskaki K; Neumann IE; Schmidt K; Stockhausen M; Hörstrup J; Cinkilic O; Flitsch-Kiefner L; Meister TL; Marheinecke C; Pfaender S; Steinmann E; Seibert FS; Stervbo U; Westhoff TH; Roch T; Babel N
    J Am Soc Nephrol; 2021 Nov; 32(11):2725-2727. PubMed ID: 34716240
    [No Abstract]   [Full Text] [Related]  

  • 13. Waning humoral response 6 months after SARS-CoV-2 vaccination with the mRNA-BNT162b2 vaccine in hemodialysis patients: time for a boost.
    Davidovic T; Schimpf J; Abbassi-Nik A; Stockinger R; Sprenger-Mähr H; Lhotta K; Zitt E
    Kidney Int; 2021 Dec; 100(6):1334-1335. PubMed ID: 34656642
    [No Abstract]   [Full Text] [Related]  

  • 14. Humoral Response and SARS-CoV-2 Infection Risk following the Third and Fourth Doses of the BNT162b2 Vaccine in Dialysis Patients.
    Einbinder Y; Perl J; Nacasch N; Bnaya A; Shavit L; Erez D; Shashar M; Halperin T; Grupper A; Benchetrit S; Wand O; Cohen-Hagai K
    Am J Nephrol; 2022; 53(7):586-590. PubMed ID: 35850101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination.
    Gonzalez-Perez M; Montes-Casado M; Conde P; Cervera I; Baranda J; Berges-Buxeda MJ; Perez-Olmeda M; Sanchez-Tarjuelo R; Utrero-Rico A; Lozano-Ojalvo D; Torre D; Schwarz M; Guccione E; Camara C; Llópez-Carratalá MR; Gonzalez-Parra E; Portoles P; Ortiz A; Portoles J; Ochando J
    Front Immunol; 2022; 13():845882. PubMed ID: 35401504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 Vaccination for Patients Undergoing Long-Term Hemodialysis.
    Korst UKH
    Clin J Am Soc Nephrol; 2022 Jun; 17(6):767-768. PubMed ID: 35649721
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical Utility of COVID-19 Vaccination in Patients Undergoing Hemodialysis.
    Oliver MJ; Blake PG
    Clin J Am Soc Nephrol; 2022 Jun; 17(6):779-781. PubMed ID: 35649720
    [No Abstract]   [Full Text] [Related]  

  • 18. Critical Stepwise Decline of Antibodies against SARS-CoV-2 among Chronic Hemodialysis Patients 180 Days Post Comirnaty Vaccine.
    Levin-Iaina N; Angel-Korman A; Leiba A; Peres E; Bryk G; Rapoport V; Katzir Z; Yagil Y; Brosh-Nissimov T
    Isr Med Assoc J; 2022 May; 24(5):317-319. PubMed ID: 35598056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral and cellular response after BNT162b2 vaccine booster in hemodialysis patients and kidney transplant recipients.
    De Cagna MR; Colucci V; Di Maggio A; Notaristefano N; Cianciotta F; Danza K; Salvatore F; Santoniccolo A; Lanzillotta SG; Perniola MA; Marangi AL; Morrone LFP; Tampoia M
    Clin Exp Nephrol; 2023 May; 27(5):445-453. PubMed ID: 36795176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral response to vaccination against SARS-CoV-2 in patients undergoing maintenance hemodialysis.
    Delgado Ureña A; Hernández García E; Varillas Caso DA
    Med Clin (Barc); 2023 Apr; 160(7):321-322. PubMed ID: 36577651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.